Taking advantage of a continuous measure of rurality, this study separates the U.S. counties into two groups as becoming-more-rural and becoming-more-urban according to whether the degree of rurality increases or decreases between 2000 and 2010, and examines the developing trends and determinants of three different types of opioid mortality, including prescription opioid-, heroin-, and synthetic opioid-involved mortality, during the years of 2010–2018. The results show significant differences in the developing trends of three types of opioid-involved mortality rates as well as in the determinants of the development of opioid-involved mortality for becoming-more-rural and becoming-more-urban counties. The study helps understanding the relationship between rurality and opioid-involved mortality, which further reflects the rural and urban difference in facing the hit of the opioid crisis.
It should be noted first that the analysis is only based on counties that have observed any prescription opioid-, heroin-, or synthetic opioid-involved deaths during 2010–2018, with a larger number of becoming-more-rural counties, mostly in the Great Plains area, being excluded since they have observed no such deaths compared to becoming-more-urban counties. This is consistent with evidence that some rural counties in the Great Plains have the lowest prescribing rates [34] and illicit drug markets are firstly developed in urban and metropolitan areas [3, 8, 21]. The overall developing trends of three opioid-involved mortality rates are similar for both groups of counties, especially that the average synthetic opioid-involved mortality has very similar values between two groups during its rapid growing period (i.e., 2014–2018). The average prescription opioid- and heroin-involved mortality rate has been stabilized and even declined after 2016 for both groups, but compared to becoming-more-urban counties, the average prescription opioid-involved mortality in becoming-more-rural counties is consistently lower while the average heroin-involved mortality rate is higher since 2014.
Though sharing some similarities, the determinants accounting for the development of opioid-involved mortality are largely different for becoming-more-rural and becoming-more-urban counties. First, the change in the degree of rurality may lead to different challenges in both groups of counties. Consistent with previous research showing that urban and metropolitan areas suffer from more rapid growth of drug overdose deaths involving synthetic opioids than rural areas [8, 35], the degree of rurality negatively correlates to synthetic opioid-involved mortality, thus becoming-more-urban counties are at a high risk of more deaths involving synthetic opioids. For becoming-more-rural counties that have heroin-involved deaths, increasing rurality correlates to increasing heroin-involved mortality, which is unexpected given that heroin use in rural areas is not as prevalent as in urban areas [6]. Thus, heroin-involved overdoses in rural areas are growing and warrant attention. Another unexpected finding is that increasing rurality does not necessarily predict the increases in the prescription opioid-involved mortality, though prescribing rates in rural areas are found higher than that in urban areas [3, 34]. This indicates that overdoses involving prescription opioids continue to be a problem in areas that becoming more urbanized.
Second, for the two types of counties, the change in opioid-involved mortality is shaped by different demographic and socioeconomic characteristics, showing that the groups with greater vulnerability in rural and urban areas may be different. For becoming-more-rural counties, the percentages of males and people engaged in manual labor occupations positively correlate with prescription opioid-involved mortality, indicating a particular disadvantage of rural counties that are dependent on labor-intensive industries. In general, counties with higher percentages of racial and ethnic minority groups have lower opioid-involved mortality, which is aligned with studies showing that these people have been hit less by the crisis compared to the white population [9, 36]. However, I also find that those becoming-more-urban counties with increasing percentages of Hispanics suffer from increasing prescription opioid-involved mortality, which may indicate a higher risk of Hispanic residents in urban areas compared to other groups. Regarding family distress, increasing percentage of people who are separated or divorced from their partners correlates to increasing prescription opioid- and heroin-involved mortality only for becoming-more-rural counties, but for becoming-more-urban counties separation or divorce decreases heroin-involved deaths. There are several explanations for this divergence. On one hand, family distress may bother rural residents more and increase their drug use due to the higher prevalence of traditional and conservative values in rural areas compared to urban areas. On the other hand, social networks may play more important roles in facilitating the circulation of illicit drugs in urban counties than in rural counties. It is found that urban drug users are more likely to obtain opioids from their family and friends than their rural counterparts are [19, 20]. Thus, separation or divorce may cut off this channel of heroin distribution for urban residents.
In addition to the supportive evidence shown in this study for the “deaths of despair” arguments that people who are socioeconomically marginalized suffer from a greater risk of drug addiction and overdose [8, 9, 37, 38], the disadvantages of the concentration of groups at risk are found particularly stronger for becoming-more-urban counties in the development of heroin- and synthetic opioid-involved mortality, compared to becoming-more-rural counties. The possible explanation is that the “drug environments” (i.e., illicit drug supplies), are more developed in urban areas than in rural areas [1–3], thus the illicit opioid crisis in urban areas is more driven by the demand-side factors and hit the groups at higher risk of socioeconomic distress and drug abuse and addiction more compared to that in rural areas. Nonetheless, due to the growing interdependency between rural and urban areas and the growing illicit drug markets (especially for illicitly manufactured fentanyl) in rural areas [3, 5], rural residents that have been disadvantaged and marginalized would increasingly suffer from the crisis. For example, the percentage of the uninsured population is found to be associated with synthetic opioid-involved mortality in becoming-more-rural counties and this association is significantly stronger than that in becoming-more-urban counties.
Third, the contrary impacts of social capital on the development of the opioid crisis, which include protecting people from drug addiction and overdoses through family and community supports [39–41] and facilitating the circulation of drugs [34, 42, 43], are shown in becoming-more-urban counties, while becoming-more-rural counties are found to suffer more from the downside of social capital. For both groups of counties, increasing social capital is related to increasing heroin- and synthetic opioid-involved mortality, which may be explained by the positive impact of social capital on the growth of illicit drug markets [44, 45]. Regarding prescription opioid-involved mortality, however, social capital show protective impacts only for becoming-more-urban counties but not for becoming-more-rural counties. This may be explained by the conservative cultures and great social and kinship networks in rural communities that restrict personal privacy and autonomy and thus cultivate the drug use stigma and prevent people from seeking treatment of addiction [6, 45–51]. These characteristics of rural communities can be strengthened by more social capital, therefore residents in rural counties with more social capital may be exposed to higher risk of drug misuse and overdose, leading to less protection that social capital has on prescription opioid-involved deaths in rural areas.
Lastly, increasing opioid supply and availability of healthcare providers generally increases opioid-involved mortality for becoming-more-urban counties while for becoming-more-rural counties the impacts of these factors are mixed. On one hand, increasing NPs are found to decrease prescription opioid- and heroin-involved mortality for becoming-more-rural counties, and the positive impact of opioid prescribing on prescription opioid-involved mortality is less strong for becoming-more-rural counties than for becoming-more-urban counties. A possible explanation is that since rural communities are underserved by healthcare providers and prescribers [3, 12], the healthcare shortage may be severer in counties that continue to lose population and become more rural. Thus in these areas, opioid prescribing may not be as harmful as that in urban areas, and residents in counties with more NPs may enjoy better healthcare services and are less likely to die from overdoses. Differently, for urban areas increasing numbers of primary care providers may reflect more demand for health problems and opioid prescriptions, thus are associated with more deaths involving both prescription opioids and illicit opioids use. On the other hand, for becoming-more-rural counties, increasing availability of NPs and PAs predicts increasing synthetic opioid-involved mortality. Moreover, opioid prescribing is negatively associated with synthetic opioid-involved mortality. These findings indicate that the development of synthetic opioid-involved mortality in rural areas may be very different from the other two types of opioid mortality. Previous literature has shown that in the current wave of the opioid crisis, synthetic opioids have become popular alternatives to prescription opioids and gradually occupied traditional illicit drug markets because of the greater potency, lower costs, and easier distribution [52, 53], and supply-side factors are major drivers of the growth of deaths involving synthetic opioids [54–56]. In counties that are becoming more rural and socioeconomic marginalized, higher percentages of primary care services may also indicate more developed synthetic opioids markets, thus correlate to higher synthetic opioid-involved mortality. In addition, the detection of synthetic opioids especially the novel ones is particularly harder than other types of opioids [57, 58], which also makes it difficult for rural healthcare providers to discover and treat synthetic opioid abuse, thus undermines the protective impacts of healthcare services on synthetic opioid overdoses.
The study is subject to several limitations. First, to compare the coefficients for two samples, the study includes the interaction of the “becoming-more-urban or becoming-more-rural” variable with all other factors into the models. The assumption of this approach is that all other covariates are the same between these two groups, which may overestimate the differences in the coefficients. For further research, the comparison could be done with more advanced methods. Second, as discussed previously, one of the most important factors is the cultural differences in rural and urban areas, but it is not easy to measure and include in the analysis. The differences in the impacts of measured variables, like social capital and the availability of healthcare services, may be explained by different cultural attributes (e.g., patient-provider relationships, privacy, drug use stigma) in these two areas. Third, the ecological fallacy and modifiable areal unit problem (MAUP) are inevitable for ecological studies. The findings need to be further evaluated in future studies based on other different levels.
Nevertheless, the study contributes to the extant literature by identifying different drivers of the development of the opioid crisis in counties that are becoming more rural and becoming more urban. The findings show that though the developing trends of opioid-involved mortality rates in the two groups of counties are generally similar, the drivers of the developments are different. Demand-side factors play more significant roles in facilitating the growth of opioid overdose deaths, especially those involving illicit drugs, in becoming-more-urban counties than in becoming-more-rural counties, possibly due to the higher availability of illicit drugs in urban areas. Becoming-more-urban counties suffer more from the concentration of socioeconomically disadvantaged groups and increasing numbers of healthcare providers than becoming-more-rural counties. However, despite the beneficial impacts of increasing availability of healthcare services on decreasing the prescription opioid- and heroin-involved deaths in becoming-more-rural areas, synthetic opioid markets may first develop in relatively better-off rural counties, leading to an inevitable growth of synthetic opioid overdoses. The findings suggest that policies and regulations for controlling the development of the opioid crisis should be localized and adjusted according to the change of the rurality of counties. For areas that are being urbanized and gaining population, communities and populations that are socioeconomically deprived and demand for more opioid and healthcare supplies deserve particular attention in the crisis, while for areas that are experiencing population loss and growing marginalized, promoting healthcare equity as well as enforcing illicit drug market disruption strategies are both important.